Lilly Recalls One Lot of Glucagon
The diabetes therapy is being recalled because of a lack of potency.
Eli Lilly is recalling one lot of Glucagon Emergency Kit for low blood sugar because of a loss of potency. Lilly has received a report saying the vial of Glucagon was in liquid form instead of the powder form. Lilly officials said in a statement that the liquid in this Glucagon vial could be related to the manufacturing process. The use of the liquid form of this product may fail to treat severe low blood sugar due to loss of potency.
Glucagon Emergency Kit is used as an anti-hypoglycemic agent and a gastrointestinal motility inhibitor indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes.
The product is packaged in a kit containing 1 mg of freeze-dried product in a 3 mL vial and a pre-filled diluent syringe. The affected Glucagon Emergency Kit lot is D239382D and the expiration date is April 2022. The lot number can be found on the label of the kit as well as the vial. The lot was distributed nationwide to wholesalers and retailers.
Glucagon product shot
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More
